What is the address of Dr. An-Katrien Seghers, gastro-enteroloog?

The registered office of Dr. An-Katrien Seghers, gastro-enteroloog is located at Spie 8, 2861 Sint-Katelijne-Waver.

Is Dr. An-Katrien Seghers, gastro-enteroloog still active?

Yes. According to the CBE (18 September 2026) Dr. An-Katrien Seghers, gastro-enteroloog is active, legal situation “Normale toestand”, started on 4 February 2021.

Is Dr. An-Katrien Seghers, gastro-enteroloog registered on Peppol?

Yes, Dr. An-Katrien Seghers, gastro-enteroloog is registered on the Peppol network with ID 0208:0762942513.

What is the enterprise number of Dr. An-Katrien Seghers, gastro-enteroloog?

The enterprise number of Dr. An-Katrien Seghers, gastro-enteroloog is BE0762942513.

When was Dr. An-Katrien Seghers, gastro-enteroloog founded?

Dr. An-Katrien Seghers, gastro-enteroloog was founded on 4 February 2021.

Who are the directors of Dr. An-Katrien Seghers, gastro-enteroloog?

According to the 2025 annual accounts, the directors of Dr. An-Katrien Seghers, gastro-enteroloog are: An-Katrien Hansje Seghers.

Is Dr. An-Katrien Seghers, gastro-enteroloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 February 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. An-Katrien Seghers, gastro-enteroloog make in 2025?

Dr. An-Katrien Seghers, gastro-enteroloog posted a profit after taxes of € 47,273 in financial year 2025.

What is the revenue of Dr. An-Katrien Seghers, gastro-enteroloog?

As a small company, Dr. An-Katrien Seghers, gastro-enteroloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 64,878.

Dr. An-Katrien Seghers, gastro-enteroloog (Private Limited)

Dossier Dr. An-Katrien Seghers, gastro-enteroloog, printed on 18 September 2026 from databakkes.be/en/0762942513/dr-an-katrien-seghers-gastro-enteroloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. An-Katrien Seghers, gastro-enteroloog from Sint-Katelijne-Waver, company number BE0762942513, closed financial year 2025 with a result of € 47,273 after tax. For that financial year Dr. An-Katrien Seghers, gastro-enteroloog recorded a gross margin of € 64,878 and equity of € 49,617. Compared with financial year 2024, the result moved from € 118,660 to € 47,273. The company is profitable. The buffer shrank hard: equity is 59 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What it is worth Shrank hard

€ 49,617

▼ 59% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 47,273

▼ 60% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 14,648

▼ 55% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 119,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 5,205

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,830

▲ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,349

▲ 16% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 39,071 Gross margin 2022: € 39,071 First fiscal year in the series	€ 102,746 Gross margin 2023: € 102,746 ▲ 163% vs 2022 (€ 39,071) Favourable step	€ 159,727 Gross margin 2024: € 159,727 ▲ 55% vs 2023 (€ 102,746) Favourable step	€ 64,878 Gross margin 2025: € 64,878 ▼ 59% vs 2024 (€ 159,727) Unfavourable step	▼ 59%
Profit after taxes	€ 27,662 Profit after taxes 2022: € 27,662 First fiscal year in the series	€ 75,722 Profit after taxes 2023: € 75,722 ▲ 174% vs 2022 (€ 27,662) Favourable step	€ 118,660 Profit after taxes 2024: € 118,660 ▲ 57% vs 2023 (€ 75,722) Favourable step	€ 47,273 Profit after taxes 2025: € 47,273 ▼ 60% vs 2024 (€ 118,660) Unfavourable step	▼ 60%
Equity	€ 67,762 Equity 2022: € 67,762 First fiscal year in the series	€ 142,684 Equity 2023: € 142,684 ▲ 111% vs 2022 (€ 67,762) Favourable step	€ 121,344 Equity 2024: € 121,344 ▼ 15% vs 2023 (€ 142,684) Unfavourable step	€ 49,617 Equity 2025: € 49,617 ▼ 59% vs 2024 (€ 121,344) Unfavourable step	▼ 59%
Total debts	€ 13,752 Total debts 2022: € 13,752 First fiscal year in the series	€ 5,908 Total debts 2023: € 5,908 ▼ 57% vs 2022 (€ 13,752) Favourable step	€ 5,559 Total debts 2024: € 5,559 ▼ 6% vs 2023 (€ 5,908) Favourable step	€ 70,728 Total debts 2025: € 70,728 ▲ € 65,169 vs 2024 (€ 5,559) Unfavourable step	▲ € 65,169
Cash	€ 29,035 Cash 2022: € 29,035 First fiscal year in the series	€ 67,112 Cash 2023: € 67,112 ▲ 131% vs 2022 (€ 29,035) Favourable step	€ 32,615 Cash 2024: € 32,615 ▼ 51% vs 2023 (€ 67,112) Unfavourable step	€ 14,648 Cash 2025: € 14,648 ▼ 55% vs 2024 (€ 32,615) Unfavourable step	▼ 55%
Retained profit	€ 65,762 Retained profit 2022: € 65,762 First fiscal year in the series	€ 140,684 Retained profit 2023: € 140,684 ▲ 114% vs 2022 (€ 65,762) Favourable step	€ 119,344 Retained profit 2024: € 119,344 ▼ 15% vs 2023 (€ 140,684) Unfavourable step	€ 47,617 Retained profit 2025: € 47,617 ▼ 60% vs 2024 (€ 119,344) Unfavourable step	▼ 60%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 800 Dividend 2023: € 800 Unchanged (€ 800) Unchanged	€ 140,000 Dividend 2024: € 140,000 ▲ € 139,200 vs 2023 (€ 800) Unchanged	€ 119,000 Dividend 2025: € 119,000 ▼ 15% vs 2024 (€ 140,000) Unchanged	▼ 15%
Balance sheet total	€ 81,515 Balance sheet total 2022: € 81,515 First fiscal year in the series	€ 148,592 Balance sheet total 2023: € 148,592 ▲ 82% vs 2022 (€ 81,515) Unchanged	€ 126,903 Balance sheet total 2024: € 126,903 ▼ 15% vs 2023 (€ 148,592) Unchanged	€ 120,345 Balance sheet total 2025: € 120,345 ▼ 5% vs 2024 (€ 126,903) Unchanged	▼ 5%

Key figures of Dr. An-Katrien Seghers, gastro-enteroloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. An-Katrien Seghers, gastro-enteroloog?

What happened at Dr. An-Katrien Seghers, gastro-enteroloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 30, 2026 New annual accounts for financial year 2025: profit of € 47,273 (▼ 60% vs 2024). Source: NBB ↗
Feb 4, 2021 New establishment in Sint-Katelijne-Waver. KBO
2021 An-Katrien Hansje Seghers became a director. NBB
Feb 4, 2021 Start of the company according to the CBE. KBO

In short

From € 27,662 profit in 2022 to € 47,273 profit in 2025.

Paid € 83,724 in corporate taxes since 2022.

Best year ever: 2024, with € 118,660 profit.

Paid out € 260,600 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. An-Katrien Seghers, gastro-enteroloog? We notify you, reason included.

Follow Dr. An-Katrien Seghers, gastro-enteroloog

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

An-Katrien Hansje Seghers

Dr. An-Katrien Seghers, gastro-enteroloog

Behind Dr. An-Katrien Seghers, gastro-enteroloog is An-Katrien Hansje Seghers.

See the full network in the app

Directors

According to the 2025 annual accounts

An-Katrien Hansje Seghers

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Spie 8

2861 Sint-Katelijne-Waver

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0762.942.513
VAT number: BE 0762.942.513
Registered office: Spie 8, 2861 Sint-Katelijne-Waver
Names & denominations: Dr. An-Katrien Seghers, gastro-enteroloog
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 February 2021
Peppol: Active · Active since 2 Sept 2025

View on CBE Public ↗ Annual accounts (NBB) ↗